Åsa Nordling
- Hepatology top 2%
- Biomedical Engineering top 10%
- Pharmacology top 1%
- Molecular Biology
- Surgery
- Co-authors
- Magnus Ingelman‐SundbergInger JohanssonVolker M. LauschkeDelilah HendriksSouren MkrtchianB. Kevin ParkSabrina MoroRowena Sison‐Young
- Topics
- Pharmacogenetics and Drug Metabolism (7 papers)Liver physiology and pathology (6 papers)Liver Disease Diagnosis and Treatment (5 papers)
- Cited by
- HepatologyPharmacologyBiochemistry
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Åsa Nordling
15 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 94
- Hepatology 460
- Biomedical Engineering 335
- Pharmacology 320
- Molecular Biology 270
- Surgery 239
Countries citing papers authored by Åsa Nordling
This map shows the geographic impact of Åsa Nordling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Åsa Nordling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Åsa Nordling more than expected).
Fields of papers citing papers by Åsa Nordling
This network shows the impact of papers produced by Åsa Nordling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Åsa Nordling. The network helps show where Åsa Nordling may publish in the future.
Co-authorship network of co-authors of Åsa Nordling
This figure shows the co-authorship network connecting the top 25 collaborators of Åsa Nordling. A scholar is included among the top collaborators of Åsa Nordling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Åsa Nordling. Åsa Nordling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 8 | |
| 3 | 8 | |
| 4 | 17 | |
| 5 | 56 | |
| 6 | 41 | |
| 7 | 2 | |
| 8 | 129 | |
| 9 | Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and diseasebreakdown → | 517 |
| 10 | 95 | |
| 11 | 24 | |
| 12 | 43 | |
| 13 | 48 | |
| 14 | 31 | |
| 15 | 102 |
About Åsa Nordling
Åsa Nordling is a scholar working on Pharmacology, Hepatology and Clinical Biochemistry, having authored 15 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (7 papers), Liver physiology and pathology (6 papers) and Liver Disease Diagnosis and Treatment (5 papers). The work is most often cited by research in Hepatology (460 citations), Pharmacology (320 citations) and Biochemistry (56 citations). Åsa Nordling has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Magnus Ingelman‐Sundberg, Inger Johansson, Volker M. Lauschke, Delilah Hendriks, Souren Mkrtchian, B. Kevin Park, Sabrina Moro, Rowena Sison‐Young, Catherine C. Bell and Ewa Ellis. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE and Hepatology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.